|
C2ORF60 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.173800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.110400E-01 |
| Normal-vs-Stage2 |
2.979800E-01 |
| Normal-vs-Stage3 |
2.525800E-01 |
| Normal-vs-Stage4 |
6.246600E-01 |
| Stage1-vs-Stage2 |
2.437800E-01 |
| Stage1-vs-Stage3 |
4.334200E-01 |
| Stage1-vs-Stage4 |
4.965000E-01 |
| Stage2-vs-Stage3 |
1.385420E-01 |
| Stage2-vs-Stage4 |
6.667400E-01 |
| Stage3-vs-Stage4 |
2.343400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.077400E-01 |
| Normal-vs-AfricanAmerican |
4.633200E-01 |
| Normal-vs-Asian |
9.527800E-01 |
| Caucasian-vs-AfricanAmerican |
4.870800E-01 |
| Caucasian-vs-Asian |
9.968600E-01 |
| AfricanAmerican-vs-Asian |
8.185400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.567000E-01 |
| Normal-vs-Female |
2.022200E-01 |
| Male-vs-Female |
1.321620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.053000E-01 |
| Normal-vs-Extreme_Weight |
1.522790E-01 |
| Normal-vs-Obese |
4.043400E-01 |
| Normal-vs-Extreme_Obese |
6.244400E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.227800E-01 |
| Normal_Weight-vs-Obese |
2.087800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.257000E-01 |
| Extreme_Weight-vs-Obese |
6.446300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.426000E-01 |
| Obese-vs-Extreme_Obese |
9.593200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.709400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.349030E-01 |
| Normal-vs-Age(61-80Yrs) |
5.635000E-01 |
| Normal-vs-Age(81-100Yrs) |
8.235800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.474600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.069570E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.253800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.128000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.786300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.908800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.345200E-01 |
| Normal-VS-Type2 PRCC |
1.070180E-02 |
| Normal-VS-KIRP CIMP |
3.330400E-01 |
| Normal-VS-Unclassified PRCC |
3.700600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.597700E-04 |
| Type1 PRCC-VS-KIRP CIMP |
3.902400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.573600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.016850E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.117600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.091800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.389900E-02 |
| Normal-vs-N1 |
1.490390E-01 |
| Normal-vs-N2 |
5.438600E-01 |
| N0-vs-N1 |
2.688400E-02 |
| N0-vs-N2 |
8.138000E-01 |
| N1-vs-N2 |
3.982800E-01 |
|
|
